SCHEMBL7349736

SCHEMBL7349736

CCCCOC(=O)c1c(C(=O)O)ccc(Cl)c1CN

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
TSHR P16473 6/20 0.46
TDP1 Q9NUW8 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
ALDH1A1 P00352 5/20 0.44
ESR1 P03372 3/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP3A4 P08684 3/20 0.43
LMNA P02545 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP2C9 P11712 1/20 0.43
PDE4D Q08499 1/20 0.43
MAPK1 P28482 3/20 0.42
TP53 P04637 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
CYP2D6 P10635 1/20 0.40
NR1H2 P55055 1/20 0.40
RNASEL Q05823 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6860628 0.77 TSHR (0.49) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL7350807 0.77 GRM6 (0.36) TSHRTDP1ALDH1A1HSD17B10LMNA
SCHEMBL7354139 0.76 TSHR (0.55) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL4627338 0.75 TSHR (0.47) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL4625869 0.75 TSHR (0.47) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL27661910 0.74 TSHR (0.51) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL11300674 0.74 TSHR (0.55) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL27300155 0.74 TSHR (0.68) TSHRTDP1L3MBTL1ALDH1A1ESR1
SCHEMBL18489476 0.73 TSHR (0.44) KMT2AMEN1TSHRTDP1L3MBTL1
SCHEMBL8007082 0.73 ALDH1A1 (0.67) KMT2AMEN1TSHRTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0691987-A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-01-17 EP disclosed
WO-1994022910-A1 CYCLIC COMPOUNDS USEFUL AS INHIBITORS OF PLATELET GLYCOPROTEIN IIb/IIIa THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-10-13 WO disclosed